Erratum: Identification of a novel, EBV-based antibody risk stratification signature for early detection of nasopharyngeal carcinoma in Taiwan (Clinical Cancer Research (2018) 24 (1305–1314) DOI: 10.1158/1078-0432.CCR-17-1929)

Anna E. Coghill; Ruth M. Pfeiffer; Carla Proietti; Wan Lun Hsu; Yin Chu Chien; Lea Lekieffre; Lutz Krause; Andy Teng; Jocelyn Pablo; Kelly J. Yu; Pei Jen Lou; Cheng Ping Wang; Zhiwei Liu; Chien Jen Chen; Jaap Middeldorp; Jason Mulvenna; Jeff Bethony; Allan Hildesheim; Denise L. Doolan

doi:10.1158/1078-0432.CCR-20-1828

Erratum: Identification of a novel, EBV-based antibody risk stratification signature for early detection of nasopharyngeal carcinoma in Taiwan (Clinical Cancer Research (2018) 24 (1305–1314) DOI: 10.1158/1078-0432.CCR-17-1929)

Anna E. Coghill, Ruth M. Pfeiffer, Carla Proietti, Wan Lun Hsu, Yin Chu Chien, Lea Lekieffre, Lutz Krause, Andy Teng, Jocelyn Pablo, Kelly J. Yu, Pei Jen Lou, Cheng Ping Wang, Zhiwei Liu, Chien Jen Chen, Jaap Middeldorp, Jason Mulvenna, Jeff Bethony, Allan Hildesheim, Denise L. Doolan

Research output: Contribution to journal › Comment/Letter to the editor › Academic

Abstract

In the original version of this article (1), the left panel of Fig. 2 was incorrectly labeled: the BFRF1 IgG antibody was incorrectly labeled as the BALF2 IgG antibody, and the corresponding sentence in the text was also incorrect. These errors have been corrected in the latest online HTML and PDF versions of the article. The authors regret these errors.

Original language	English
Pages (from-to)	3496
Number of pages	1
Journal	Clinical cancer research : an official journal of the American Association for Cancer Research
Volume	26
Issue number	13
DOIs	https://doi.org/10.1158/1078-0432.CCR-20-1828
Publication status	Published - 1 Jul 2020

Access to Document

10.1158/1078-0432.CCR-20-1828

Cite this

Coghill, A. E., Pfeiffer, R. M., Proietti, C., Hsu, W. L., Chien, Y. C., Lekieffre, L., Krause, L., Teng, A., Pablo, J., Yu, K. J., Lou, P. J., Wang, C. P., Liu, Z., Chen, C. J., Middeldorp, J., Mulvenna, J., Bethony, J., Hildesheim, A., & Doolan, D. L. (2020). Erratum: Identification of a novel, EBV-based antibody risk stratification signature for early detection of nasopharyngeal carcinoma in Taiwan (Clinical Cancer Research (2018) 24 (1305–1314) DOI: 10.1158/1078-0432.CCR-17-1929). Clinical cancer research : an official journal of the American Association for Cancer Research, 26(13), 3496. https://doi.org/10.1158/1078-0432.CCR-20-1828

Coghill, Anna E. ; Pfeiffer, Ruth M. ; Proietti, Carla et al. / Erratum : Identification of a novel, EBV-based antibody risk stratification signature for early detection of nasopharyngeal carcinoma in Taiwan (Clinical Cancer Research (2018) 24 (1305–1314) DOI: 10.1158/1078-0432.CCR-17-1929). In: Clinical cancer research : an official journal of the American Association for Cancer Research. 2020 ; Vol. 26, No. 13. pp. 3496.

@article{7c9a99b9e8de438c9e297148e51e6376,

title = "Erratum: Identification of a novel, EBV-based antibody risk stratification signature for early detection of nasopharyngeal carcinoma in Taiwan (Clinical Cancer Research (2018) 24 (1305–1314) DOI: 10.1158/1078-0432.CCR-17-1929)",

abstract = "In the original version of this article (1), the left panel of Fig. 2 was incorrectly labeled: the BFRF1 IgG antibody was incorrectly labeled as the BALF2 IgG antibody, and the corresponding sentence in the text was also incorrect. These errors have been corrected in the latest online HTML and PDF versions of the article. The authors regret these errors.",

author = "Coghill, {Anna E.} and Pfeiffer, {Ruth M.} and Carla Proietti and Hsu, {Wan Lun} and Chien, {Yin Chu} and Lea Lekieffre and Lutz Krause and Andy Teng and Jocelyn Pablo and Yu, {Kelly J.} and Lou, {Pei Jen} and Wang, {Cheng Ping} and Zhiwei Liu and Chen, {Chien Jen} and Jaap Middeldorp and Jason Mulvenna and Jeff Bethony and Allan Hildesheim and Doolan, {Denise L.}",

year = "2020",

month = jul,

day = "1",

doi = "10.1158/1078-0432.CCR-20-1828",

language = "English",

volume = "26",

pages = "3496",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

number = "13",

}

Coghill, AE, Pfeiffer, RM, Proietti, C, Hsu, WL, Chien, YC, Lekieffre, L, Krause, L, Teng, A, Pablo, J, Yu, KJ, Lou, PJ, Wang, CP, Liu, Z, Chen, CJ, Middeldorp, J, Mulvenna, J, Bethony, J, Hildesheim, A & Doolan, DL 2020, 'Erratum: Identification of a novel, EBV-based antibody risk stratification signature for early detection of nasopharyngeal carcinoma in Taiwan (Clinical Cancer Research (2018) 24 (1305–1314) DOI: 10.1158/1078-0432.CCR-17-1929)', Clinical cancer research : an official journal of the American Association for Cancer Research, vol. 26, no. 13, pp. 3496. https://doi.org/10.1158/1078-0432.CCR-20-1828

Erratum : Identification of a novel, EBV-based antibody risk stratification signature for early detection of nasopharyngeal carcinoma in Taiwan (Clinical Cancer Research (2018) 24 (1305–1314) DOI: 10.1158/1078-0432.CCR-17-1929). / Coghill, Anna E.; Pfeiffer, Ruth M.; Proietti, Carla et al.

In: Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 26, No. 13, 01.07.2020, p. 3496.

Research output: Contribution to journal › Comment/Letter to the editor › Academic

TY - JOUR

T1 - Erratum

T2 - Identification of a novel, EBV-based antibody risk stratification signature for early detection of nasopharyngeal carcinoma in Taiwan (Clinical Cancer Research (2018) 24 (1305–1314) DOI: 10.1158/1078-0432.CCR-17-1929)

AU - Coghill, Anna E.

AU - Pfeiffer, Ruth M.

AU - Proietti, Carla

AU - Hsu, Wan Lun

AU - Chien, Yin Chu

AU - Lekieffre, Lea

AU - Krause, Lutz

AU - Teng, Andy

AU - Pablo, Jocelyn

AU - Yu, Kelly J.

AU - Lou, Pei Jen

AU - Wang, Cheng Ping

AU - Liu, Zhiwei

AU - Chen, Chien Jen

AU - Middeldorp, Jaap

AU - Mulvenna, Jason

AU - Bethony, Jeff

AU - Hildesheim, Allan

AU - Doolan, Denise L.

PY - 2020/7/1

Y1 - 2020/7/1

N2 - In the original version of this article (1), the left panel of Fig. 2 was incorrectly labeled: the BFRF1 IgG antibody was incorrectly labeled as the BALF2 IgG antibody, and the corresponding sentence in the text was also incorrect. These errors have been corrected in the latest online HTML and PDF versions of the article. The authors regret these errors.

AB - In the original version of this article (1), the left panel of Fig. 2 was incorrectly labeled: the BFRF1 IgG antibody was incorrectly labeled as the BALF2 IgG antibody, and the corresponding sentence in the text was also incorrect. These errors have been corrected in the latest online HTML and PDF versions of the article. The authors regret these errors.

UR - http://www.scopus.com/inward/record.url?scp=85087473944&partnerID=8YFLogxK

U2 - 10.1158/1078-0432.CCR-20-1828

DO - 10.1158/1078-0432.CCR-20-1828

M3 - Comment/Letter to the editor

C2 - 32611629

AN - SCOPUS:85087473944

VL - 26

SP - 3496

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 13

ER -

Coghill AE, Pfeiffer RM, Proietti C, Hsu WL, Chien YC, Lekieffre L et al. Erratum: Identification of a novel, EBV-based antibody risk stratification signature for early detection of nasopharyngeal carcinoma in Taiwan (Clinical Cancer Research (2018) 24 (1305–1314) DOI: 10.1158/1078-0432.CCR-17-1929). Clinical cancer research : an official journal of the American Association for Cancer Research. 2020 Jul 1;26(13):3496. doi: 10.1158/1078-0432.CCR-20-1828

Erratum: Identification of a novel, EBV-based antibody risk stratification signature for early detection of nasopharyngeal carcinoma in Taiwan (Clinical Cancer Research (2018) 24 (1305–1314) DOI: 10.1158/1078-0432.CCR-17-1929)

Abstract

Access to Document

Other files and links

Cite this